Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004348984 | SCV004072132 | uncertain significance | not specified | 2023-06-27 | criteria provided, single submitter | clinical testing | The c.1749C>G (p.F583L) alteration is located in exon 18 (coding exon 18) of the LGR5 gene. This alteration results from a C to G substitution at nucleotide position 1749, causing the phenylalanine (F) at amino acid position 583 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |